Breaking News, Collaborations & Alliances

HCATS and Invetech Enter Cell Therapy Mfg. Collaboration

New partnership for automated cell therapy manufacturing platform

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Hitachi Chemical Advanced Therapeutics Solutions (HCATS), a U.S. subsidiary of Hitachi Chemical, that engages in contract manufacturing and development of regenerative medicine products, and Invetech, a developer and producer of automated manufacturing solutions for cell and advanced therapies, have entered a collaboration agreement to commercialize an automated platform for cell therapy manufacturing, the Counter-Flow Centrifugation system (CFC). The collaboration will enhance the development a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters